Association with HLA-DRβ1 position 37 distinguishes juvenile dermatomyositis from adult-onset myositis.


Journal

Human molecular genetics
ISSN: 1460-2083
Titre abrégé: Hum Mol Genet
Pays: England
ID NLM: 9208958

Informations de publication

Date de publication:
21 07 2022
Historique:
received: 10 09 2021
revised: 14 01 2022
accepted: 17 01 2022
pubmed: 31 1 2022
medline: 27 7 2022
entrez: 30 1 2022
Statut: ppublish

Résumé

Juvenile dermatomyositis (JDM) is a rare, severe autoimmune disease and the most common idiopathic inflammatory myopathy of children. JDM and adult-onset dermatomyositis (DM) have similar clinical, biological and serological features, although these features differ in prevalence between childhood-onset and adult-onset disease, suggesting that age of disease onset may influence pathogenesis. Therefore, a JDM-focused genetic analysis was performed using the largest collection of JDM samples to date. Caucasian JDM samples (n = 952) obtained via international collaboration were genotyped using the Illumina HumanCoreExome chip. Additional non-assayed human leukocyte antigen (HLA) loci and genome-wide single-nucleotide polymorphisms (SNPs) were imputed. HLA-DRB1*03:01 was confirmed as the classical HLA allele most strongly associated with JDM [odds ratio (OR) 1.66; 95% confidence interval (CI) 1.46, 1.89; P = 1.4 × 10-14], with an independent association at HLA-C*02:02 (OR = 1.74; 95% CI 1.42, 2.13, P = 7.13 × 10-8). Analyses of amino acid positions within HLA-DRB1 indicated that the strongest association was at position 37 (omnibus P = 3.3 × 10-19), with suggestive evidence this association was independent of position 74 (omnibus P = 5.1 × 10-5), the position most strongly associated with adult-onset DM. Conditional analyses also suggested that the association at position 37 of HLA-DRB1 was independent of some alleles of the Caucasian HLA 8.1 ancestral haplotype (AH8.1) such as HLA-DQB1*02:01 (OR = 1.62; 95% CI 1.36, 1.93; P = 8.70 × 10-8), but not HLA-DRB1*03:01 (OR = 1.49; 95% CR 1.24, 1.80; P = 2.24 × 10-5). No associations outside the HLA region were identified. Our findings confirm previous associations with AH8.1 and HLA-DRB1*03:01, HLA-C*02:02 and identify a novel association with amino acid position 37 within HLA-DRB1, which may distinguish JDM from adult DM.

Identifiants

pubmed: 35094092
pii: 6517526
doi: 10.1093/hmg/ddac019
pmc: PMC9307311
doi:

Substances chimiques

Amino Acids 0
HLA-C Antigens 0
HLA-DRB1 Chains 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2471-2481

Subventions

Organisme : Versus Arthritis
ID : 21552
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 085860
Pays : United Kingdom
Organisme : NIAMS NIH HHS
ID : R01 AR063759
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067677
Pays : United States
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N003322/1
Pays : United Kingdom

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press.

Références

Nat Genet. 2012 Jan 29;44(3):291-6
pubmed: 22286218
Nat Genet. 2016 Oct;48(10):1279-83
pubmed: 27548312
Hum Mutat. 2007 Oct;28(10):968-77
pubmed: 17492639
Arthritis Care Res (Hoboken). 2012 Aug;64(8):1233-7
pubmed: 22422616
Nat Genet. 2016 Oct;48(10):1284-1287
pubmed: 27571263
Arthritis Res Ther. 2012 Apr 30;14(2):R97
pubmed: 22546500
PLoS Genet. 2013 Nov;9(11):e1003926
pubmed: 24278027
Am J Hum Genet. 2014 Apr 3;94(4):522-32
pubmed: 24656864
Proc Natl Acad Sci U S A. 2020 Jan 7;117(1):552-562
pubmed: 31871193
Curr Opin Rheumatol. 2015 Nov;27(6):601-7
pubmed: 26352731
Genes Immun. 2015 Oct;16(7):470-80
pubmed: 26291516
Nat Genet. 2015 Feb;47(2):172-9
pubmed: 25559196
Arthritis Rheum. 1996 Sep;39(9):1507-18
pubmed: 8814062
Am J Hum Genet. 2011 Mar 11;88(3):294-305
pubmed: 21376301
Proc Natl Acad Sci U S A. 2010 Sep 28;107(39):16899-903
pubmed: 20837527
Ann Rheum Dis. 2012 May;71(5):710-3
pubmed: 22258483
Nature. 2007 Dec 6;450(7171):887-92
pubmed: 18004301
Nature. 2010 Sep 2;467(7311):52-8
pubmed: 20811451
Medicine (Baltimore). 2019 Nov;98(48):e18218
pubmed: 31770283
Medicine (Baltimore). 2006 Mar;85(2):111-127
pubmed: 16609350
Gigascience. 2015 Feb 25;4:7
pubmed: 25722852
Hum Immunol. 1997 Apr 15;54(1):30-9
pubmed: 9154455
Arthritis Rheum. 2006 Nov;54(11):3670-81
pubmed: 17075818
Nat Commun. 2017 Jul 17;8:16021
pubmed: 28714469
J Rheumatol. 2009 Nov;36(11):2547-51
pubmed: 19833756
Arthritis Rheum. 2013 Nov;65(11):2954-62
pubmed: 24037894
Ann Rheum Dis. 2012 Jun;71(6):961-5
pubmed: 22186711
Arthritis Rheum. 2013 Dec;65(12):3239-47
pubmed: 23983088
Rheumatology (Oxford). 2014 Dec;53(12):2204-8
pubmed: 24987158
Hepatology. 2011 Jun;53(6):1967-76
pubmed: 21413052
Ann Rheum Dis. 2019 Jun;78(6):773-780
pubmed: 30936065
Ann Rheum Dis. 2016 Apr;76(4):765-772
pubmed: 27998952
Genes Immun. 2004 May;5(3):203-8
pubmed: 15029234
PLoS One. 2013 Jun 06;8(6):e64683
pubmed: 23762245
Ann Rheum Dis. 2016 Aug;75(8):1558-66
pubmed: 26362759
Ann Rheum Dis. 2019 Jul;78(7):996-1002
pubmed: 31138531
Proc Natl Acad Sci U S A. 2015 Dec 29;112(52):15970-5
pubmed: 26598658
Immunobiology. 1996 Aug;195(3):261-70
pubmed: 8877401
Arthritis Res Ther. 2006;8(1):R13
pubmed: 16507114
Br J Dermatol. 1998 Dec;139(6):978-83
pubmed: 9990359
Nat Commun. 2015 Feb 05;6:6046
pubmed: 25651891
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Am J Hum Genet. 2014 Aug 7;95(2):162-72
pubmed: 25087609
Medicine (Baltimore). 2013 Jul;92(4):223-243
pubmed: 23877355
Rheumatology (Oxford). 2015 Jan;54(1):50-63
pubmed: 25065005
Hum Mol Genet. 2018 Nov 15;27(22):3901-3910
pubmed: 30084967
Nat Genet. 2007 Jul;39(7):906-13
pubmed: 17572673
PLoS Genet. 2019 Apr 25;15(4):e1008092
pubmed: 31022184
Nat Genet. 2010 Jul;42(7):565-9
pubmed: 20562875

Auteurs

Claire T Deakin (CT)

Infection, Immunity and Inflammation Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, London, UK.
Centre for Adolescent Rheumatology Versus Arthritis at UCL, UCL Hospital and Great Ormond Street Hospital, London, UK.
NIHR Biomedical Research Centre at Great Ormond Street Hospital, London, UK.

John Bowes (J)

Centre for Genetics and Genomics Versus Arthritis, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
National Institute of Health Research Manchester Biomedical Research Centre, Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, Manchester, UK.

Lisa G Rider (LG)

Environmental Autoimmunity Group, Clinical Research Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD, USA.

Frederick W Miller (FW)

Environmental Autoimmunity Group, Clinical Research Branch, National Institute of Environmental Health Sciences, National Institutes of Health, Bethesda, MD, USA.

Lauren M Pachman (LM)

Ann & Robert H. Lurie Children's Hospital of Chicago, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

Helga Sanner (H)

Department of Rheumatology, University of Oslo, Oslo, Norway.
Oslo New University College, Oslo, Norway.

Kelly Rouster-Stevens (K)

Emory University School of Medicine, Atlanta, GA, USA.

Gulnara Mamyrova (G)

Division of Rheumatology, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.

Rodolfo Curiel (R)

Division of Rheumatology, George Washington University School of Medicine and Health Sciences, Washington, DC, USA.

Brian M Feldman (BM)

Division of Rheumatology, Department of Pediatrics, The Hospital for Sick Children, Toronto, ON, Canada.

Adam M Huber (AM)

IWK Health Centre and Dalhousie University, Halifax, NS, Canada.

Ann M Reed (AM)

Pediatrics, Duke University, Durham, NC, USA.

Heinrike Schmeling (H)

Department of Pediatrics, Alberta Children's Hospital, University of Calgary, Calgary, AB, Canada.

Charlotte G Cook (CG)

Infection, Immunity and Inflammation Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, London, UK.

Lucy R Marshall (LR)

Infection, Immunity and Inflammation Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, London, UK.
Centre for Adolescent Rheumatology Versus Arthritis at UCL, UCL Hospital and Great Ormond Street Hospital, London, UK.
NIHR Biomedical Research Centre at Great Ormond Street Hospital, London, UK.

Meredyth G Ll Wilkinson (MG)

Infection, Immunity and Inflammation Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, London, UK.
Centre for Adolescent Rheumatology Versus Arthritis at UCL, UCL Hospital and Great Ormond Street Hospital, London, UK.
NIHR Biomedical Research Centre at Great Ormond Street Hospital, London, UK.

Stephen Eyre (S)

Centre for Genetics and Genomics Versus Arthritis, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
National Institute of Health Research Manchester Biomedical Research Centre, Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, Manchester, UK.

Soumya Raychaudhuri (S)

Centre for Genetics and Genomics Versus Arthritis, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK.
National Institute of Health Research Manchester Biomedical Research Centre, Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, Manchester, UK.
Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Lucy R Wedderburn (LR)

Infection, Immunity and Inflammation Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, London, UK.
Centre for Adolescent Rheumatology Versus Arthritis at UCL, UCL Hospital and Great Ormond Street Hospital, London, UK.
NIHR Biomedical Research Centre at Great Ormond Street Hospital, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH